Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have been given an average recommendation of “Hold” by the eighteen analysts that are covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and nine have given a buy rating to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $45.92.
A number of research analysts have commented on ACHC shares. Jefferies Group set a $60.00 target price on Acadia Healthcare and gave the company a “buy” rating in a research note on Wednesday, October 11th. BidaskClub downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Friday, August 18th. Citigroup lowered their target price on Acadia Healthcare from $61.00 to $44.00 and set a “buy” rating on the stock in a research note on Wednesday, October 25th. Cantor Fitzgerald lowered their target price on Acadia Healthcare from $48.00 to $39.00 and set a “neutral” rating on the stock in a research note on Tuesday, October 24th. Finally, Deutsche Bank downgraded Acadia Healthcare from a “buy” rating to a “hold” rating and lowered their target price for the company from $60.00 to $37.00 in a research note on Wednesday, October 25th.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Capstone Asset Management Co. bought a new stake in Acadia Healthcare during the 2nd quarter valued at approximately $420,000. LS Investment Advisors LLC bought a new stake in Acadia Healthcare during the 2nd quarter valued at approximately $312,000. Aperio Group LLC boosted its stake in Acadia Healthcare by 20.4% during the 2nd quarter. Aperio Group LLC now owns 28,817 shares of the company’s stock valued at $1,423,000 after purchasing an additional 4,891 shares during the period. State Treasurer State of Michigan bought a new stake in Acadia Healthcare during the 2nd quarter valued at approximately $1,555,000. Finally, US Bancorp DE boosted its stake in Acadia Healthcare by 5.8% during the 2nd quarter. US Bancorp DE now owns 33,585 shares of the company’s stock valued at $1,658,000 after purchasing an additional 1,845 shares during the period.
Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Tuesday, October 24th. The company reported $0.58 earnings per share for the quarter, missing the consensus estimate of $0.65 by ($0.07). Acadia Healthcare had a net margin of 6.07% and a return on equity of 8.57%. The business had revenue of $716.70 million for the quarter, compared to analyst estimates of $728.86 million. During the same period in the previous year, the firm posted $0.58 earnings per share. The firm’s quarterly revenue was down 2.4% on a year-over-year basis. sell-side analysts anticipate that Acadia Healthcare will post 2.23 earnings per share for the current year.
TRADEMARK VIOLATION NOTICE: This article was first reported by American Banking News and is the property of of American Banking News. If you are reading this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The correct version of this article can be read at https://www.americanbankingnews.com/2017/12/01/acadia-healthcare-company-inc-achc-receives-consensus-recommendation-of-hold-from-analysts.html.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.